« back

Pharma Digital Collaboration

Sustainable development of healthcare systems and effective response to global challenges require close collaboration between pharma, governments, civil society, and international organizations. Digital, data-driven decision support systems play a key role in strengthening clinical decision-making, enabling personalized therapies, and improving quality of care. Such multilateral, institutionalized collaborations can mobilize collective knowledge and resources, expand healthcare access, and reinforce global health security.

Pharma Digital Collaboration

From Drug Development to Digital Health: Building Integrated Ecosystems How pharma companies can move beyond traditional R&D and embrace digital health as part of their therapeutic offering. Partnerships with digital health startups, health systems, and regulators.

Clinical Decision Support Systems (CDSS): Enabling Data-Driven Therapies The role of CDSS in guiding clinical decision-making, personalizing treatments, and improving patient outcomes. How pharma can contribute by integrating trial data, real-world evidence, and digital biomarkers into these systems.

Data Interoperability and Trust: Breaking Down Silos in Healthcare Creating frameworks for data sharing between pharma, health systems, and public health institutions. Addressing challenges of privacy, cybersecurity, and patient trust.

Scaling Access in Underserved Regions: Pharma’s Role in Global Health Equity How digital platforms and decision support tools can make treatments more accessible. Models for cross-sector collaboration to strengthen healthcare resilience in vulnerable regions.

Value-Based Care and Digital Therapeutics: New Business Models for Pharma Integrating digital health solutions into reimbursement and value-based frameworks. Pharma’s role in shaping sustainable financial models for digital-enabled therapies.

Regulatory and Policy Innovation: Enabling Safe but Rapid Adoption How regulators, pharma, and international organizations can co-create adaptive frameworks. Lessons learned from COVID-19 in fast-tracking digital health adoption.

Strengthening Global Health Security through Multilateral Collaboration Joint efforts between pharma, WHO, NGOs, and governments to prepare for future health crises. The role of digital surveillance, early warning systems, and shared therapeutic data.

Human-Centered Innovation: Designing Digital Health for Clinicians and Patients Ensuring usability and clinical relevance of decision support tools. Co-creation approaches with patients, physicians, and pharma stakeholders.

Dr. Judit Bidló, PharmD


Deputy State Secretary for the Professional Management of Health, Ministry of the Interior

Sean R. Smith


Managing Director, MSD

Balázs Sinkovits


Government Affairs and Market Access Lead, AstraZeneca

dr. Veronika Kovács


Partner, Coordinator of the CEE Public Procurement Practice, CMS